Clinical trial
An Examination of Predictors of Indicators of Response to Celecoxib in Women Who…
NCT00291122 · University of Kansas, Other · Completed
Key facts
| NCT number | NCT00291122 |
|---|---|
| Title | An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer |
| Official title | Quantitative Real Time PCR in Formalin Fixed Breast Tissue From Biopsy and Re-Excision Specimens: An Ancillary Protocol to a Chemoprevention Trial of Celecoxib |
| Lead sponsor | University of Kansas, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | celecoxib 400 mg BID |
| Enrollment | 100 |
| Start date | Jan 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | Feb 13, 2006 |
| Last update posted | Sep 16, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: